Receptors and Signaling II

• Definition and Alternative Names: Ionotropic receptors, also known as ligand-gated ion channels, are specialized proteins located in the membranes of cells. These receptors play a crucial role in transmitting signals within the body by allowing certain ions, such as sodium or calcium, to flow in and out of the cell when activated by specific ligands, which can be thought of as the keys that unlock these channels.

• Structural Composition: These receptors are made up of multiple smaller units called subunits that span the cell membrane. Together, these subunits create a central channel or pore. This structure is essential because it allows selective ions to pass through, depending on whether the receptor has been activated or not.

• General Mechanism of Action:

  • The parts of the receptor located outside the cell (called the extracellular domains) have special sites where specific molecules (ligands) can attach. For example, neurotransmitters are chemical signals in the body that can bind to these receptors.

  • When a ligand binds to the receptor, a change in the shape (conformational change) of the receptor occurs, leading to the opening of the channel.

  • Once this channel is open, ions like sodium ($Na^+$) or calcium ($Ca^{2+}$) can flow into the cell, following their natural tendency to move from areas of higher concentration to lower concentration (electrochemical gradients). This flow of ions is integral to processes such as muscle contraction and nerve signal transmission.

• Prevalence in Mammalian Systems: Compared to another type of receptor called G protein-coupled receptors (GPCRs), ionotropic receptors are not as common in mammalian systems. This difference means that while both types of receptors are crucial for cell signaling, ionotropic receptors represent a smaller fraction of the signaling pathways in mammalian physiology.

• Case Study: Nicotinic Acetylcholine Receptor (nAChR):
  
  

  • Context: Acetylcholine is a neurotransmitter released from nerve cells that communicates with other nearby cells in a targeted way (paracrine signaling).

  • Location: nAChRs are found on certain cells, including adrenal chromaffin cells, which are involved in the body's stress response.

  • Physiological Response: When acetylcholine binds to the nicotinic receptor, the ion channel opens up, allowing $Ca^{2+}$ to enter the adrenal chromaffin cell. This sudden influx of calcium is crucial because it triggers these cells to release epinephrine (a hormone also known as adrenaline) into the bloodstream, preparing the body for fight-or-flight responses.

Catalytic Receptors: Overview and Classification

• General Features: Catalytic receptors are a diverse group of receptors in the body. They are similar to GPCRs in their variety and functions. These receptors generally consist of three parts: an extracellular domain that binds to ligands, a transmembrane domain that spans the cell membrane, and an intracellular catalytic domain capable of causing a chemical reaction inside the cell.

• Dimerization: One of the key characteristics of many catalytic receptors is that when a ligand binds to the receptor, it often causes two receptor molecules to come together (dimerize). This process effectively activates the receptor's signaling capabilities, turning it into a functional unit that sends signals into the cell.

• Functional Goal: The main purpose of these receptors is to initiate a specific action within the cell through the activation of the intracellular catalytic region. This activation can lead to various cellular responses, depending on the type of receptor and the ligand involved.

• Five Major Classes of Catalytic Receptors:
  
  

  1. Receptor guanylyl cyclases.

  2. Receptor serine/threonine kinases.

  3. Receptor tyrosine kinases.

  4. Tyrosine kinase-associated receptors.

  5. Receptor tyrosine phosphatases.

Receptor Guanylyl Cyclases

• Structure: These receptors are unique because they are an intrinsic part of the receptor itself. They include membrane-spanning domains that pair up (dimerize), along with an extracellular domain and an intracellular domain that has catalytic abilities.

• Example: Atrial Natriuretic Peptide (ANP) Receptor:
  
  

  • Activation: When ANP binds to the receptor's extracellular portion, it prompts the receptors to dimerize and change shape.

  • Conformational Change: This change enables the receptor to activate its guanylyl cyclase activity.

  • Enzymatic Activity: This activation leads to the conversion of Guanosine Triphosphate (GTP) into cyclic Guanosine Monophosphate (cGMP) ($GTP \rightarrow cGMP$).

  • Downstream Signaling: The cGMP produced signals further reactions within the cell, activating various targets like Protein Kinase G (PKG) and influencing ion channels to adjust cell functions accordingly.

Receptor Tyrosine Kinases (RTKs)

• Structural Defining Feature: The distinct feature of RTKs is that their catalytic part, called tyrosine kinase, resides within the receptor's intracellular section.

• Example 1: Nerve Growth Factor (NGF) Receptor:
  
  

  • When NGF binds to the receptor, it causes two receptors to come together and activate.

  • This prompts the tyrosine kinase to phosphorylate various proteins in the cell, which is vital for processes like cell growth and survival.

• Example 2: Insulin Receptor:
  
  

  • Structure: The insulin receptor has a unique shape as it is made up of two types of subunits: two alpha chains and two beta chains.

  • Activation: Insulin (a hormone that helps regulate blood sugar) binds to the alpha chains. This causes a shift that allows the beta chains to communicate with each other.

  • Mechanism: This interaction activates the intrinsic tyrosine kinase found in the beta chains. This activation leads to the phosphorylation of specific proteins in the cell, key for regulating glucose levels and other metabolic processes.

Tyrosine Kinase-Associated Receptors

• Structural Difference from RTKs: Unlike RTKs, these receptors don't have tyrosine kinase activity built into their structure.

• Mechanism of Recruitment: When a ligand binds and changes the shape of these receptors, they bind to independent tyrosine kinases found in the cytosol.

• Example: Interleukin-6 (IL-6) Receptor:
  
  

  • These receptors often consist of different subunits, like an alpha subunit and a beta subunit.

  • Dimerization Varieties:

    • Homodimers: two of the same subunit join together (e.g., alpha-alpha).

    • Heterodimers: different subunits come together (e.g., alpha-beta).

    • Heterotetramers: an even more complex joining of different subunits (e.g., alpha-beta-alpha-beta).

  • Associated Kinases: Once activated, these receptors bring associated kinases like Janus kinase (JAK) or Src into action, which then proceed to phosphorylate proteins inside the cell and initiate further signaling cascades.

Intracellular Receptors: Steroid and Thyroid Hormones

• Ligand Characteristics: Intracellular receptors are designed to respond to lipid-soluble molecules such as steroid hormones, vitamin D metabolites ($1,25\text{-dihydroxvitamin } D_3$), and thyroid hormones. These ligands can easily cross the protective cell membrane due to their structure.

• Location: The receptors are found either in the cytoplasm or within the nucleus of the cell, where they can directly influence gene activity.

• Function as Transcription Factors: Once these hormones bind to their receptors, they enable the receptors to act as transcription factors, which are proteins that control the process of gene transcription by binding to specific sections of DNA called Hormone Response Elements (HREs).

• Genomic Effects: This interaction leads to either increasing or decreasing the production of specific proteins within the cell, significantly affecting cell function.

• Dimerization on DNA: The receptors ultimately need to form dimers—a pairing of two receptors—to bind to DNA effectively.

• Dimerization Patterns:
  
  

  • MR (Mineralocorticoid Receptor): Can form two identical receptors (homodimers) or pair with the Glucocorticoid Receptor (heterodimers).

  • GR (Glucocorticoid Receptor): Similar options for dimerization.

  • ER alpha (Estrogen Receptor alpha): Forms both homodimers and heterodimers with ER beta.

  • Other receptors (AR and PR): Follow comparable dimerization patterns.

  • TR, VDR, and RAR: These do not form homodimers but pair with the Retinoid X Receptor (RXR).

• Intracellular Localization by Type:
  
  

  • Mostly Cytoplasmic: Glucocorticoid Receptor (GR) and Mineralocorticoid Receptor (MR) are predominantly found in the cytoplasm when inactive.

  • Mostly Nuclear: Estrogen Receptor (ER) and Progesterone Receptor (PR) are typically located in the nucleus, where they actively influence gene expression.

  • DNA-bound in Nucleus: Thyroid Hormone Receptor (TR) is usually found in the nucleus already associated with DNA.

Specific Mechanisms of Intracellular Receptor Activation

• Thyroid Hormone Receptor (TR) Action:
  
  

  • Resting State: When not activated, TR remains in the nucleus, attached to RXR and the DNA. In the absence of the thyroid hormone ($T\text{3}$), TR functions as a repressor, inhibiting certain genes from being expressed.

  • Activation: Once $T\text{3}$ enters the cell and binds with the receptor, it triggers the transcription of specific genes, effectively activating them.

• Glucocorticoid Receptor (GR) Action:
  
  

  • Resting State: GR resides in the cytosol, held inactive by a protein called Heat Shock Protein 90 (HSP 90).

  • Activation: When cortisol (the ligand) enters the cell and binds to GR, it causes HSP 90 to detach, activating the receptor.

  • Nuclear Entry: Now activated, the GR forms a homodimer and moves into the nucleus to bind to DNA, starting the process of transcription for specific genes.

• Non-Genomic Actions: Besides these long-term genomic effects, hormones can also provoke rapid effects that do not involve changes in gene expression, showcasing their versatility in regulating cellular functions. These rapid actions are becoming an exciting area of scientific inquiry.

Disease and Therapeutic Implications of Receptor Signaling

• Importance of Research: Comprehending how receptors signal is essential for grasping how cells function normally and for developing new treatments, including drugs and gene therapies.

• Pathological Defects: A variety of diseases stem from faults in receptors or their signaling pathways.

• Case study: Pseudohypoparathyroidism:
  
  

  • Normal Physiology: Under healthy conditions, parathyroid hormone (PTH) works on the kidneys and bones to elevate blood calcium levels by utilizing the $G\text{α}_s$ protein in the PTH receptor pathway.

  • Pathology: In pseudohypoparathyroidism, a defect in the $G\text{α}_s$ protein prevents PTH from carrying out its function, leading to low blood calcium levels (hypocalcemia).

• Case study: Nephrogenic Diabetes Insipidus:
  
  

  • Normal Physiology: Vasopressin (also known as Antidiuretic Hormone, ADH) operates via V2 receptors in the kidneys to enhance water reabsorption and consequently regulate blood volume.

  • Pathology: In nephrogenic diabetes insipidus, a defect in V2 receptors causes vasopressin to be ineffective, resulting in excessive water loss through urine and diluted urine output.

• Case study: Hypothyroidism (Autoimmune):
  
  

  • Pathology: In this condition, autoimmune antibodies target TSH receptors on thyroid cells. This autoantibody action prevents TSH from stimulating the production and release of thyroid hormones, which ultimately leads to lower blood levels of these hormones, resulting in various health issues.